1 active not recruiting, 1 recruiting. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Active not recruiting 1, Recruiting 1 |
Follow daromun: new trials by email Literature Review of daromun trials Research Report on daromun
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients Daromun, Surgery, Adjuvant therapy - Melanoma Stage IIIB, Melanoma Stage IIIC | Phase 3 | Recruiting | Philogen S.p.A. | 186 | 2018-09-20 | 2025-12-17 |
| Neoadjuvant L19IL2/L19TNF- Pivotal Study L19IL2 + L19TNF, Surgery - Malignant Melanoma | Phase 3 | Active not recruiting | Philogen S.p.A. | 214 | 2016-07-01 | 2024-09-19 |
Melanoma (2)
Philogen S.p.A. (2)
France (1) · Germany (1) · Italy (1) · Poland (1) · Spain (1) · Switzerland (1) · United States (1)
Caroline Robert, MD (1) · Mario Santinami, MD (1) · Piotr Rutkowski, MD (1)
PMID 36648215, PMID 31538818, PMID 40633690, PMID 42579833
2023 (1)